论文部分内容阅读
应用放射免疫法测定189例甲状腺疾病患者血清β2微球蛋白(β2-MG),结果提示Graves病未治组血清β2-MG增高,其它组及Graves病治疗缓解组血清β2-MG变化不显著。血T3、T4分别与β2-MG呈正相关。测定血清β-2MG变化对Graves病的诊断、病情估价及判断抗甲状腺药物的疗效提供了佐证。
Serum β2-microglobulin (β2-MG) was measured by radioimmunoassay in 189 patients with thyroid disease. The results showed that the serum β2-MG was not elevated in patients with Graves disease and the serum β2-MG was not significantly different in other groups and Graves disease-treated patients. Blood T3, T4 and β2-MG were positively correlated. Serum β-2MG changes in the diagnosis of Graves disease, disease evaluation and determine the efficacy of anti-thyroid drugs provide evidence.